GSK:LON
GSK plc
1 770,83 GBX
arrow_upward
+1,19%(+20,83) 1D
12 tet, 6:17:16 m.d., GMT+1 · GBX
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për GSK...
Hap
1 755,00 GBX
I lartë
1 771,00 GBX
I ulët
1 751,00 GBX
Kapitalizimi i tregut
94,34 mld
Vëllimi mesatar
5,90 mln
Vëllimi
3,15 mln
Dividendi
3,84%
Dividendi tremujor
17,00 GBX
Data e ndërprerjes së dividendit
13 gush 2026
Raporti çmim/fitim
15,01
Maksimumi 52-javor
2 282,00 GBX
Minimumi 52-javor
1 592,00 GBX
Fitimet për aksion
1,18 GBX
Aksionet në qarkullim
4,32 mld
Numri i punonjësve
67 mijë
Hap
1 755,00 GBX
I lartë
1 771,00 GBX
I ulët
1 751,00 GBX
Kapitalizimi i tregut
94,34 mld
Vëllimi mesatar
5,90 mln
Vëllimi
3,15 mln
Dividendi
3,84%
Dividendi tremujor
17,00 GBX
Data e ndërprerjes së dividendit
13 gush 2026
Raporti çmim/fitim
15,01
Maksimumi 52-javor
2 282,00 GBX
Minimumi 52-javor
1 592,00 GBX
Fitimet për aksion
1,18 GBX
Aksionet në qarkullim
4,32 mld
Numri i punonjësve
67 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Patch
·
1 orë më parë
Pharma Giant GSK To Expand In Upper Merion, Investing $800 Million
TipRanks
·
4 orë më parë
GSK Executives Reinvest Dividends in Routine Share Acquisitions
Endpoints News
·
4 orë më parë
GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania
ad-hoc-news.de
·
6 orë më parë
GSK stock costs EUR 20.89 with USD 93.2 billion market value
Profili
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Rreth GSK plc
Drejtori ekzekutivEmma Walmsley | Emma Walmsley
Punonjësit66,8 mijë
Themeluar më27 dhj 2000
Selia-
Sektori-
Uebsajtigsk.com